Insider Stock Trading History of Dallas Matthew D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dallas Matthew D since year 2005. The trader's CIK number is 1612396. At the time of this reporting, Dallas Matthew D is the Chief Financial Officer of Colucid Pharmaceuticals, Inc. . (stock ticker symbol CLCD). See this page for all insider trading activities at Colucid Pharmaceuticals, Inc. .

Note that in the past Dallas Matthew D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Dallas Matthew D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-03 CLCD Colucid Pharmaceuticals, Inc. Sale 1,473 36.25 53,396
2016-12-01 CLCD Colucid Pharmaceuticals, Inc. Sale 1,473 35.17 51,800
2015-01-16 AVEO Aveo Pharmaceuticals Inc Sale 3,075 .82 2,512
2015-01-07 AVEO Aveo Pharmaceuticals Inc Sale 519 .80 415

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dallas Matthew D (Chief Financial Officer of Colucid Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.